共 4 条
[1]
Intraperitoneal 5-fluoro-2′-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study[J] . Valerie K. Israel,Chun Jiang,Franco M. Muggia,Anil Tulpule,Susan Jeffers,Lawrence Leichman,C. Paul Morrow,Lynda Roman,C. Gail Leichman,Kenneth K. Chan.Cancer Chemotherapy and Pharmacology . 1995 (1)
[3]
Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine[J] . Franco M. Muggia,Kenneth K. Chan,Christy Russell,Nicoletta Colombo,James L. Speyer,Kishore Sehgal,Susan Jeffers,Joan Sorich,Lawrence Leichman,Uziel Beller,E. Mark Beckman.Cancer Chemotherapy and Pharmacology . 1991 (4)
[4]
Antitumor activity of the weekly push schedule of 5-fluoro-2′-deoxyuridine ± Nphosphonacetyl -L-aspartate in mice bearing advanced colon carcinoma 26 .2 Van Laar JAM,Durrani FA,Rustum YM. Cancer Res . 1993